Sonali Thosani, M.D.
Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine
About Dr. Sonali Thosani
Dr. Sonali Thosani is an Associate Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at the University of Texas MD Anderson and the Section Chief for Diabetes. Dr. Thosani is certified in medical quality and is the Patient Safety Quality Officer for Division of Internal Medicine and Department of Endocrinology. She is also the Operations Medical Director for the Glycemic Management Program.
She grew up in Oklahoma City and graduated Summa cum laude from Oklahoma City University with a Bachelor of Arts and Science in Spanish and Biology. After graduating from the University of Oklahoma medical school, she completed a residency training program in Internal Medicine and Pediatrics at UT-Houston, and an Endocrinology fellowship at Baylor College of Medicine.
She has been a faculty member at MD Anderson since 2012, and her clinical and research interests include treatment of diabetes and steroid induced hyperglycemia in cancer patients, and designing ways to improve the quality and delivery of health care in the inpatient and outpatient setting. Dr. Thosani is multilingual and fluent in Spanish, Hindi and Gujarati.
Present Title & Affiliation
Primary Appointment
Operations Medical Director-Glycemic Control, Department of Endocrine Neoplasia and Hormonal Disorders, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Section Chief, Diabetes, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX
Adjunct Assistant Professor, Department of Internal Medicine, Baylor College of Medicine, Houston, TX
Research Interests
Management of steroid induced hyperglycemia
Quality improvement in health care delivery
Endocrine effects of cancer chemotherapy
Clinical Interests
Dr. Thosani enjoys taking care of patients with diabetes and endocrine complications of cancer treatment including thyroid disorders, hypogonadism and bone health disorders. In addition, she work on improving the quality of care delivered to patients across various settings.
For general clinic information and referrals, please visit the Department of Endocrine Neoplasia and Hormonal Disorders' contact information webpage at:
Contact Information
Education & Training
Degree-Granting Education
| 2006 | University of Oklahoma College of Medicine, Oklahoma City, Oklahoma, US, MD |
| 2002 | Oklahoma City University, Oklahoma City, Oklahoma, US, Spanish, BA |
| 2002 | Oklahoma City University, Oklahoma City, Oklahoma, US, Biology, BS |
Postgraduate Training
| 2010-2012 | Endocrinology Fellowship, Baylor College of Medicine, Houston, Texas |
| 2007-2010 | Medicine/Pediatrics Residency, UT Health, Houston, Houston, Texas |
| 2006-2007 | Medicine/Pediatric Internship, University of Oklahoma College of Medicine, Oklahoma, Oklahoma |
Licenses & Certifications
| 2024 | DEA Certification |
| 2024 | Basic Life Support |
| 2024 | Alabama Board of Medical Examiners |
| 2023 | Mississippi State Board of Medical Licensure |
| 2023 | Georgia Composite Medical Board |
| 2023 | Oklahoma State Board of Medical Licensure |
| 2023 | Tennessee Board of Medical Examiners |
| 2023 | Arizona Board of Medical Examiners |
| 2023 | Louisiana State Board of Medical Examiners |
| 2023 | Washington State Department of Health |
| 2021 | Texas Medical Board |
| 2021 | Florida Board of Medicine |
| 2013 | American Board of Internal Medicine, Endocrinology |
| 2011 | American Board of Pediatrics |
| 2010 | American Board of Internal Medicine, Internal Medicine |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2020
Administrative Appointments/Responsibilities
Certified trainer for High Reliability Organization Training: Leadership Skills and Universal Skills, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022
Patient Safety Quality Officer, Department of Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present
Physician Lead for QAPI Hyperglycemia PFA, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Patient Safety Quality Officer, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2025
Rotation Program Coordinator, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2016
Rotation Program Coordinator, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2021
EHR Officer, Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2016
Subject Matter Expert for Diabetes, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2016
Other Professional Positions
Board Member, Texas Endocrine Association, 2024 - Present
Vice President, Texas Endocrine Association, 2024 - Present
Board Member of Directors, Texas Association of Clinical Endocrinology, Houston, TX, 2019 - 2023
Fellow Representative for Harris County Quality Improvement Conference, Baylor College of Medicine, Houston, TX, 2011
Chief Medical Resident, UT Health, Houston, Houston, TX, 2009 - 2010
Member of Residency Council, UT Health, Houston, Houston, TX, 2008 - 2009
Committee Member for Medical School Admissions Boards, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2007
Extramural Institutional Committee Activities
Member, Quality Management Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, ECMS, The University of Texas MD Anderson Cancer Center, 2023 - Present
Co-chair, Clinical Effectiveness Subcommittee, The University of Texas MD Anderson Cancer Center, 2023 - Present
MDACC Representative, UT-HIP Expert Panel, The University of Texas MD Anderson Cancer Center, 2021 - 2022
Chair, DoIM Quality Council, The University of Texas MD Anderson Cancer Center, 2020 - Present
Vice Chair, DoIM Quality Council, The University of Texas MD Anderson Cancer Center, 2019 - 2020
Member, Continuing Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2020
Member, Clinical Effectiveness Subcommittee, The University of Texas MD Anderson Cancer Center, 2012 - 2015
Honors & Awards
| 2025 - Present | Fellow of the American Association of Clinical Endocrinology, American Association of clinical Endocrinology |
| 2024 | Quality improvement Poster Competition, DoIM Research Retreat 2024 |
| 2023 | Award for Professionalism Excellence (APEX), Center for Professionalism Support and Success (CPSS) MD Anderson |
| 2023 | Graduate of LEADing Teams Core Cohort-June, MD Anderson Leadership Institute |
| 2023 - Present | Fellow of endocrine Alliance Academy, Endocrine Alliance |
| 2021 | Division of Internal Medicine Excellence in Quality Improvement Award, Division of Internal Medicine |
| 2021 | Presidential Recognition of Excellence in Clinical Quality Improvement |
| 2021 | Six Sigma Yellow Belt Certification |
| 2019 | Quality Improvement Poster finalist, Division of Internal Medicine Research Retreat |
| 2012 | Women in Endocrinology, Young Investigator Award, Endocrine Society |
| 2010 | American Association of Clinical Endocrinology - Fellows in Training Representative, American Association of Clinical Endocrinology |
| 2009 | Humanism in Medicine Award |
| 2006 | Finalist for Dean’s Award |
| 2006 - Present | Presenter for Finalist in Dean’s Award, OU College of Medicine |
| 2006 - Present | Presenter of Humanism in Medicine, OU College of Medicine |
| 2004 | Columbia/HCA Foundation Scholarship |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Triple Threat: Diabetes, Cancer and Cardiovascular Disease. Invited. Cardiology Grand Rounds. Houston, Texas, US.
- 2025. Pitfalls in Point of Care Glucose Monitoring. Invited. DM Academic Meeting. Houston, Texas, US.
- 2025. Insulin Pump Therapy and CGM use in the Oncology Patient. Invited. Diabetes Lecture Series. Houston, Texas, US.
- 2023. 2023 Updates. Conference. Quality Improvement Council. Houston, Texas, US.
- 2021. Diabetes and Hyperglycemia Management in Cancer Patients. Conference. Houston, TX, US.
- 2021. Inpatient Glycemic Management at MD Anderson: the past, the present, and the future!. Invited. DoIM Grand Rounds. Houston, Texas, US.
- 2021. Hypoglycemia: "The Biggest Barriers to Hyperglycemia Treatment". Invited. Education Series. Houston, Texas, US.
- 2020. Glycemic Management Action Team: update and future plans. Invited. DoIM Grand Rounds. Houston, Texas, US.
- 2020. 2020 Division of Internal Medicine Quality and Safety Report. Invited. 2020 Division of Internal Medicine Quality and Safety Report. Houston, TX, US.
- 2020. Quality and Safety Report. Invited. Cancer Survivorship Grand Rounds. Houston, Texas, US.
- 2019. ICT Grand Rounds. Invited. ICT Grand Rounds. Houston, Texas, US.
- 2017. Improving Documentation and Management of Hypoglycemia through Protocol Adherence: A Quality Improvement Initiative. Conference. Improving Documentation and Management of Hypoglycemia through Protocol Adherence: A Quality Improvement Initiative, US.
- 2014. Peri-operative Glycemic Management in Cancer Patients. Invited. Anesthesia Grand Rounds. Houston, Texas, US.
- 2013. Improvement of Hypoglycemia Management in Hospitalized Patients:. Conference. Improvement of Hypoglycemia Management in Hospitalized Patients:, US.
- Glycemic Management Action Team: Update and Future Plans. Invited. Glycemic Management Action Team: Update and Future Plans. Houston, TX, US.
Regional Presentations
- 2023. Setting up a Remote CGMS clinic: Enhancing patient Care and practice efficiency. Conference. Setting up a Remote CGMS clinic: Enhancing patient Care and practice efficiency. Houston, US.
- 2023. Sweet Success: Implementation of House Wide Glycemic Initiative. Conference. Sweet Success: Implementation of House Wide Glycemic Initiative, US.
- 2021. Endocrine adverse effects of Immunotherapy. Conference. Endocrine adverse effects of Immunotherapy. San Antonio, TX, US.
- 2018. Diabetes and Cancer Risk. Conference. Diabetes and Cancer Risk. Houston, US.
National Presentations
- 2025. Integrating Quality Improvement into Inpatient Diabetes Care. Invited. Meet the Professor Session. San Francisco, California, US.
- 2025. Finding the sweet spot: Achieving Glucose control in patients on Nutrition Support Therapy. Invited. American Society of Parenteral and Enteral Nutrition. Columbus, Ohio, US.
- 2024. 2024 Update in Thyroid Disorders. Invited. MER Conference. Orlando, Florida, US.
- 2024. Osteoporosis Update 2024. Invited. MER Conference. Orlando, Florida, US.
- 2024. Type 2 DM Update 2024. Invited. MER Conference. Orlando, Florida, US.
- 2024. Update on Type 1 Diabetes and Insulin Therapy. Invited. MER Conference. Orlando, Florida, US.
- 2024. Hyperglycemia Management in Nutrition Support Patients. Invited. American Society for Parenteral and Enteral Nutrition (ASPEN) meeting. Tampa, FL, US.
- 2023. Integrating Quality Improvement into Clinical Practice. Conference. Integrating Quality Improvement into Clinical Practice. Seattle, WA, US.
- 2021. Endocrine adverse effects of Immunotherapy. Conference. San Antonio, TX, US.
- 2020. Insulin Therapy for Diabetes. Visiting. MER Conference. Nassau, BS.
- 2020. Type 2 Diabetes Mellitus. Visiting. MER Conference. Nassau, BS.
- 2020. Obesity Management Update 2020. Visiting. MER Conference. Nassau, BS.
- 2020. Management of Dyslipidemia. Visiting. MER Conference. Nassau, BS.
- 2018. Immunotherapy induced insulin dependent diabetes: a cancer center experience. Conference. Immunotherapy induced insulin dependent diabetes: a cancer center experience, US.
- 2014. Management of Steroid induced hyperglycemia in Cancer Patients. Conference. Oncologic Care of Cancer Patient, US.
- 2011. Pseudohypoparathyroidism and Increased Bone Mineral Density. Conference. Pseudohypoparathyroidism and Increased Bone Mineral Density, US.
- 2011. Severe Constipation and Uncontrolled Hypertension. Conference. Severe Constipation and Uncontrolled Hypertension, US.
Formal Peers
- 2025. Insulin Pump Therapy and CGM use int he Oncology Patient. Houston, Texas, US.
- 2024. Characterizing ICI-induced diabetes, US.
- 2024. Insulin Pump Therapy and CGMs in the Oncology Patient. Houston, Texas, US.
- 2023. Diagnosis and Management of patients with type 1 Diabetes and Insulin Pump. Houston, Texas, US.
- 2023. What's New in DKA Management. Houston, Texas, US.
- 2023. HRO Universal Skills Course. Houston, Texas, US.
- 2023. Osteoporosis Update. Visiting. Washington, DC, US.
- 2023. Management of Type 1 Diabetes and Insulin Therapy. Visiting. Washington, DC, US.
- 2023. Update on Thyroid Disease Management. Visiting. Washington, DC, US.
- 2023. Update on Type 2 Diabetes Management. Visiting. Washington, DC, US.
- 2023. Management of Patients with Type 1 diabetes and Cancer, US.
- 2022. Osteoporosis: Diagnosis and Management in 2022. Conference. Newport, RI, US.
- 2022. Type 2 diabetes mellitus: Diagnosis and Management. Conference. Newport, RI, US.
- 2022. Thyroid Disorders in Women: Diagnosis and Management (2022). Conference. Newport, RI, US.
- 2022. Insulin Therapy, Injectables and Diabetes Technology in 2022. Conference. Newport, RI, US.
- 2022. Universal Skill Course. HRO Training. Houston, Texas, US.
- 2022. Management of Hyperglycemic Emergencies. Houston, Texas, US.
- 2022. Optimizing Glycemic Management in Cancer Patients. Houston, Texas, US.
- 2022. Improving Hyperglycemia management in Pediatric patients. Houston, Texas, US.
- 2022. Universal Skills. High Reliability Organizational Training. Houston, Texas, US.
- 2022. Inpatient Hyperglycemia Management in Cancer Patients. Houston, Texas, US.
- 2022. Leadership skills. High reliability Organizational Training. Houston, Texas, US.
- 2022. Endocrine Case Conference. Conference. Oahu, HI, US.
- 2022. Thyroid Disorders. Conference. Oahu, HI, US.
- 2022. Insulin Treatment in Diabetes. Conference. Oahu, HI, US.
- 2022. Osteoporosis: Diagnosis and Treatment. Conference. Oahu, HI, US.
- 2022. Type 2 Diabetes. Conference. Oahu, HI, US.
- 2022. Osteoporosis: Comprehensive Update 2022. Conference. Oahu, HI, US.
- 2022. Thyroid Disorders in Women: Diagnosis and Management. Conference. Oahu, HI, US.
- 2022. Endocrinology Case Reviews. Conference. Oahu, HI, US.
- 2022. Diagnosis and Management of Type 2 diabetes mellitus: 2022 update. Conference. Oahu, HI, US.
- 2022. Insulin Therapy, Diabetes Technology and Injectables in 2022. Conference. Oahu, HI, US.
- 2022. Presentation on Diabetes and Cancer Patient. Houston, Texas, US.
- 2022. Hyperglycemia Management in Cancer patient. Houston, Texas, US.
- 2022. Leadership skills. High reliability Organizational Training. Houston, Texas, US.
- 2022. Universal Skills. High Reliability Organizational Training. Houston, Texas, US.
- 2022. Update on Glycemic Management Policy and Hyperglycemia Algorithm. Houston, Texas, US.
- 2022. Improving hyperglycemia management at MD Anderson. Houston, Texas, US.
- 2021. Improving hyperglycemia management at MD Anderson. Houston, Texas, US.
- 2021. Inpatient Diabetes Management: What's new?. Houston, Texas, US.
- 2021. Perioperative Management of Hyperglycemia. Houston, Texas, US.
- 2021. Barriers and Special Populations in a Cancer Hospital for Inpatient Glycemic Management. Houston, Texas, US.
- 2021. Hyperglycemic Emergencies in Cancer Patients. Houston, Texas, US.
- 2021. Multidisciplinary approach to improving glucose management in patients at high risk of DKA. Houston, Texas, US.
- 2020. Outpatient and Perioperative Diabetes Management. Visiting. Houston, TX, US.
- 2020. Immunotherapy Induced Endocrinopathies. Visiting. Houston, TX, US.
- 2020. Endocrine Case Conference: Hyperglycemic Emergencies. Visiting. Houston, TX, US.
- 2020. Immunotherapy Induced Endocrinopathies. Houston, Texas, US.
- 2020. Management of Hyperglycemia and Hyperglycemic Emergencies. Houston, Texas, US.
- 2020. A Multidisciplinary Approach to Prevent Hyperglycemic Emergencies in High-Risk Patients. Houston, Texas, US.
- 2020. DKA/HHS Management - Hyperglycemic Emergencies. Houston, Texas, US.
- 2020. Encounters with Hyperglycemic Cancer Patients in the Emergency Room. Houston, Texas, US.
- 2020. Project proposal: Quality Assessment Performance Improvement (QAPI) Board. Houston, Texas, US.
- 2019. Osteoporosis Update 2019. Conference. Orlando, FL, US.
- 2019. Case Presentations: Calcium Disorders 2019 update. Conference. Orlando, FL, US.
- 2019. Thyroid Disorders in Women. Conference. Washington DC, US.
- 2019. Osteoporosis Update 2019. Conference. Washington DC, US.
- 2019. Calcium Disorders. Conference. Washington DC, US.
- 2019. Calcium Disorders: Case Presentations. Washington, DC, US.
- 2019. Hyperglycemic Emergencies in the ICU. Houston, Texas, US.
- 2019. Endocrine Side Effects of Immunotherapy. Houston, Texas, US.
- 2019. General Outpatient Management Highlighting Checkpoints. Houston, Texas, US.
- 2018. Osteoporosis Management for Primary Care Physicians. Conference, US.
- 2018. Metabolic Bone Disease. Conference. Hilton Head, SC, US.
- 2018. Case Presentations: Calcium Disorders. Conference. Hilton Head, SC, US.
- 2018. Disorders of Calcium Metabolism. Conference. Hilton Head, SC, US.
- 2018. Management of Obesity: 2018 update. Conference. Los Angeles, CA, US.
- 2018. Thyroid Disorders in Women. Conference, US.
- 2018. Case Presentations: Obesity Management and Osteoporosis. Conference. Los Angeles, CA, US.
- 2018. Osteoporosis Update 2018. Conference, US.
- 2017. Endocrine Board Review. Houston, Texas, US.
- 2016. Diagnosis and Management of Hypothyroidism. Houston, Texas, US.
- 2016. Diagnosis and Management of Hyperthyroidism. Houston, Texas, US.
- 2016. Diagnosis and Management of Hypothyroidism. Houston, Texas, US.
- 2015. Management of Hyperglycemia in Cancer Patients. Houston, Texas, US.
Grant & Contract Support
| Date: | 2021 - 2025 |
| Title: | PET Imaging of ROS Burst in Immune Adverse Events: First-in-Human Evaluation |
| Funding Source: | NIH |
| Role: | OSC |
| ID: | PA-20-183 |
Selected Publications
Peer-Reviewed Articles
- Gandhi, A, Jeun, R, Wang, Z, Khan, S, Best, CJ, Lavis, VR, Thosani, S. Etiologies and Outcomes of Diabetic Ketoacidosis in Cancer Patients. Cancers 17(17), 2025. e-Pub 2025. PMID: 40940823.
- Gandhi A, Jeun R, Wang Z, Khan S, Best C, Lavis V, Thosani S. Etiologies and Outcomes of Diabetic Ketoacidosis in Cancer Patients: A Retrospective Analysis. Cancers 17(17), 2025. e-Pub 2025.
- Kotian, Anoop, Cain, Katherine, Moser, Tanner, Patel, Rina, Warren, Mary Lou, Thosani, Sonali. Decreasing Insulin Induced Hypoglycemia with Education of a New Multimodal Hyperkalemia Order Set for Patients Admitted to a Cancer Center. Journal of Oncology Pharmacy Practice, 2025. e-Pub 2025. PMID: 40718910.
- Berkman AM, Andersen CR, Dixon SB, Ramirez A, Gilmore K, Thoman W, Razouki ZA, Santos D, Thosani S, Livingston J, T Hildebrandt MA, Roth ME. Weight-Related Outcomes among Survivors of Adolescent and Young Adult Cancer after Anti-Obesity Medication Initiation. Journal of Adolescent and Young Adult Oncology, 2025. e-Pub 2025. PMID: 40452567.
- Moussa, MJ, Wilson, NR, Ghosh, A, Bhattacharjee, M, Curry, JL, Cho, WC, Patel, A, Habra, MA, Thosani, S, Campbell, M, Siefker-Radtke, AO, Alhalabi, O, Kikani, NJ. Systemic Toxicity With Hyperglycemia or Diabetic Ketoacidosis After Enfortumab Vedotin. Annals of Internal Medicine Clinical Cases 4(5), 2025. e-Pub 2025.
- Taylor, JS, Fellman, B, Cain, K, Iniesta-Donate, M, Earles, T, Harris, M, James, DA, Siebel, C, Lasala, J, Mena, GE, Raty, S, Popovich, SM, Vu, KD, Thosani, S, Best, CJ, Schmeler, KM, Ramirez, PT, Meyer, LA. Glycemic control to improve post-operative outcomes in patients with type 2 diabetes mellitus. International Journal of Gynecological Cancer 35(1), 2025. e-Pub 2025. PMID: 39878292.
- Taylor J, Fellman B, Raty S, Lasala J, Iniesta M, Cain K, Horner A, Bruno M, Folloder J, Knippel S, Khanh V, Popovich S, Katz M, Best C, Thosani S. Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center. Annals of Surgical Oncology 31(5):3017-3023, 2024. e-Pub 2024. PMID: 38347330.
- Jeun R, Iyer PC, Best C, Lavis V, Varghese JM, Yedururi S, Brady V, Glitza Oliva IC, Dadu R, Milton DR, Brock K, Thosani S. Clinical Outcomes of immune checkpoint inhibitor diabetes mellitus at a comprehensive cancer center. Immunotherapy 15(6):417-428, 2023. e-Pub 2023. PMID: 37013834.
- Jeun R, Lavis VR, Thosani S. Diabetic Ketoacidosis With Alpelisib. Journal of Endocrine Society 5(1), 2021. e-Pub 2021. PMID: 8089606.
- Jeun R, Lavis V, Thosani S. Diabetic Ketoacidosis upon Initiation of Alpelisib: Two Case Reports. Clinical Oncology Case Reports 4(3), 2021. e-Pub 2021.
- Jozaghi Y, Zafereo M, Perrie ND, Wang JR, Grubbs E, Gross ND, Fisher S, Sturgis EM, Goepfert RP, Lai SY, Best CJ, Busaidy NL, Cabanillas ME, Dadu R, Gagel RF, Habra MA, Hu M, Jimenez C, Sherman S, Thosani S, Varghese J, Waguespack S, Weitzman S, Ying AK, Graham PH. Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines. Head & Neck 42(6):1325-1328, 2020. e-Pub 2020. PMID: 32437031.
- Bedrose S, Turin CG, Lavis VR, Kim ST, Thosani S. A case of acquired generalized lipodystrophy associated with Pembrolizumab in a patient with metastatic malignant melanoma. AACE Clinical Case Reports 6(1):e40-e45, 2020. e-Pub 2020. PMID: 32524008.
- Iyer P, Cabanillas M, Waguespack S, Hu M, Thosani S, Lavis V, Busaidy N, Subudhi S, Diab A, Dadu R. Immune-Related Thyroiditis with Immune Checkpoint Inhibitors. Thyroid 10:1243-1251, 2018. e-Pub 2018. PMID: 30132401.
- Pinnix CC, Cella L, Andraos TY, Ayoub Z, Milgrom SA, Gunther J, Thosani S, Wogan C, Conson M, D'Avino V, Oki Y, Fanale M, Lee HJ, Neelapu S, Faya L, Hagemeister F, Robriguez MA, Nastoupil LJ, Nieto Y, Qiao W, Pacelli R, Dabaja B. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics 101(3):530-540, 2018. e-Pub 2018. PMID: 29681481.
- Thosani S, Ayala-Ramirez M, Roman-Gozalez A, Zhou S, Thosani N, Bisanz A, Jimenez C. Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma. European Journal of Endocrinology 173(3):377-87, 2015. e-Pub 2015. PMID: 26060051.
- Brady V, Thosani S, Zhou S, Bassett R, Busaidy NL, Lavis VR. Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy. Diabetes Technology & Therapeutics 16(12):874-9, 2014. e-Pub 2014. PMID: 25321387.
- Thosani S, Ayala-Ramirez M, Hu M, Palmer L, Rich T, Gagel R, Cote G, Waguespack SG, Habra MA, Jimenez C. The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2. The Journal of Endocrinology and Metabolism 98(11):E1813-19, 2013. e-Pub 2013. PMID: 24030942.
Invited Articles
- Best CJ, Thosani S, Ortiz M, Levesque C, Varghese S, Lavis VR. Co-Managing Patients with Type 1 Diabetes and Cancer. Current Diabetes Reports 16(8):73, 2016. e-Pub 2016. PMID: 27319323.
- Thosani S, Hu M. Denosumab: a new agent in the management of hypercalcemia of malignancy. Future Oncology 11(21):2865-71, 2015. e-Pub 2015. PMID: 26403973.
Review Articles
- Iyer P, Kikani N, Khan S, Chaudhri A, Pagnotti G, Best C, Weitzman S, Mehta P, Lavis V, Thosani S, Gandhi A, Schneider R, Varghese J, Guise T, Dadu R. The evolving management of endocrine disorders induced by checkpoint inhibitors: insights from the CIITED group. Taylor & Francis, 2025. e-Pub 2025.
- Kotwal A, Kennedy R, Thosani S, Kikani N, Goldner W, Shariff A. Endocrinopathies Associated With Immune Checkpoint Inhibitor Use. Endocrine Practice 30(6):584-591, 2024. e-Pub 2024. PMID: 38554775.
- Jimenez P, Tatsui C, Jessop A, Thosani S, Jimenez C. Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress. Current Oncology Reports 19:83, 2017. e-Pub 2017. PMID: 29081018.
- Thosani S, Jimenez C. Opioid-induced biochemical alterations of the neuroendocrine axis. Expert Review of Endocrinology & Metabolism 6(5):705-703, 2014. e-Pub 2014. PMID: 30780884.
- Yeung Ching-Sai, Habra MA, Thosani S. Lung cancer-induced paraneoplastic syndromes. Current Opinion in Pulmonary Medicine 17(4):260-8, 2011. e-Pub 2011. PMID: 21577115.
- Thosani N, Thosani S, Qiao W, Fleming JB, Bhutani MS, Guha S. Role of EUS-FNA-based cytology in the diagnosis of mucinous pancreatic cystic lesions: a systematic review and meta-analysis. Digestive Diseases and Sciences, 2010. e-Pub 2010. PMID: 20694512.
- Pollard LM, Sharma R, Gómez M, Shah S, Delatycki MB, Pianese L, Monticelli A, Keats BJ, Bidichandani SI. Replication-mediated instability of the GAA triplet repeat mutation in Friedreich ataxia. Nucleic Acids Research, 2004. e-Pub 2004. PMID: 15534367.
Professional Educational Materials
- Thosani S. Teaching Patients Glucometer Use and Insulin Therapy. MD Anderson Cancer Center, 2025.
- Thosani S. Diabetes Survival Skills: Essential Knowledge for Patient Teaching in Managing Diabetes During Cancer Treatment. MD Anderson Cancer Center, 2025.
- Thosani S. Optimizing Nursing Workflow for Comprehensive Inpatient Diabetes Education and Care. MD Anderson Cancer Center, 2025.
- Thosani, Sonali. Diabetes Management: Practice Pearls for the Impatient Oncology Nurse. MD Anderson Education Center, 2024.
- Thosani, Sonali. Basal Bolus insulin therapy. MD Anderson Education Center. MD Anderson Education Center, 2021.
- Thosani Sonali. Hyperglycemic Emergencies: DKA and HHS. MD Anderson Education Center, 2020.
- Thosani, Sonali. Caring for Patients with Insulin Pumps. MD Anderson Education Center, 2020.
- Thosani, Sonali. Diabetes Mellitus. MD Anderson Education Center, 2020.
- Thosani Sonali. Hypoglycemia: Accurately managing and documenting hypoglycemia treatment in Hospitalized patients. MD Anderson Education Center, 2017.
Other Articles
- Thosani N, Thosani S, Kumar S, Nugent Z, Jimenez C, Singh H, Guha S Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis. Journal of Clinical Oncology 31(5):623-30, 2012. PMID: 23269990.
Abstracts
- Osafehinti, Deborah, Thosani, Sonali, Weitzman,Steven. Investigating Glycemic Risk Index Trends for Patients with Comorbid Cancer and Diabetes Evaluated in Remote Monitoring Clinic. Diabetes Therapeutics and Technology Meeting. e-Pub 2025.
- Ayush Gandhi MD, Rebecca Jeun MD, Sonya Khan MD, Conor Best MD, Victor Lavis MD, Sonali Thosani MD. Diabetic Ketoacidosis in Cancer Patients: Etiological Patterns in a Tertiary Care Center. Endocrine Society Meeting, 2025.
- Donovan D, Highsmith E, Khan S, Thosani S, Horng M. Impact of decision support tool on ICU Rebound hyperglycemia. American Association of Clinical Endocrinology Meeting, 2025.
- Mehta P, Gore S, Bassett R, Guk-Ong B, Mathew J, Millil J, Lalani S, Balajadia B, Grami P, Mathew S, Thosani S. Evaluating Patient Experience of Diabetes Care Services. American Association of Clinical Endocrinology Meeting, 2025.
- Thosani S. Integrating Obesity Screening and Management in Cancer Survivorship Care. American Society of Metabolic and Bariatric Surgery, 2024. e-Pub 2024.
- Thosani S. Enhancing Toxocity Monitoring for Patients with Advanced Thyroid Cancer on Targeted Therapy. ENDO 2024, 2024. e-Pub 2024.
- Thosani S, Hamidi S, Castellanos L, Best C, Sherman S, Dadu R, Brinkman A, Khoja M, Hu M, Waguespack S, Weitzman S. Real-Life Safety Monitoring for Patients with Advanced Thyroid Cancer on Targeted Therapy: A Quality Improvement Project. Endocrine Society, 2024. e-Pub 2024.
- Thosani S, Thomas W, Gilmore K, Kazantsev T, Garcia W, Warr H, Chapman P, Basen-Engquist K, Bevers T, Chang L, Crawford K, Crowder R, Hwang J, Lopez G, Morse M, Rodriquez M, Sukumar J, Roth M, Santos D. Integrating Obesity Screen and Managements in Cancer Survivorship Care. ASMBS Conference, 2024. e-Pub 2024.
- Monroy A, Khan S, Kikani N, Brady VJ, Thosani SN. Hyperglycemia in a novel CDK2 and CDK9 inhibitor- Fadraciclib, 2024. e-Pub 2024.
- Thosani S, Crowder V, Grami P, and Kikani N. Sweet success: Implementation of institution wide glycemic management initiative, 2024. e-Pub 2024.
- Kikani N, Palma D, Brady VJ, Thosani SN. Use of Continuous Glucose Monitoring System versus Capillary Point of care testing for inpatient Glucose monitoring in a cancer hospital. Poster Presentation, 2024. e-Pub 2024.
- Patil M, Thosani S, Wang Z, Bassett R, Guise T. “Treatment with denosumab for osteoporosis with Metastatic disease to bone is associated with hypercalcemia.”. American Society of Bone and Mineral Research, 2023. e-Pub 2023.
- Ngo E, Thosani S. Covid-19 Outcomes in Cancer Patients with Diabetes. Poster presentation. Endocrine Society, 2023. e-Pub 2023.
- Thosani S, Kikani N. Identifying Trends in Glycemic Management in a Comprehensive Cancer Center. Poster presentation. Division of Internal Medicine Research Retreat, 2023. e-Pub 2023.
- Nguyen, Son, Thosani S. Enfortumab Vedotin associated refractory diabetic ketoacidosis, rash and altered mental status. Poster presentation, 2023. e-Pub 2023.
- Thosani S. Denosumab Withdrawal Is Associated With Hypercalcemia In Adults With Osteoporosis And Bone Metastases, 2023. e-Pub 2023.
- Ngo, E, Thosani, S. Neurologic and Clinical Manifestations of Cancer Patients with Checkpoint Inhibitor Diabetes and GAD65 Antibody Positivity, 2023. e-Pub 2023.
- Kikani NI, Thosani, sonali. Identifying Trends in Glycemic Management in the Acute Cancer Care Center at MD Anderson Cancer Center. Emergency Medicine Oncology Conference, 2023. e-Pub 2023.
- Thosani SN, Laura K, Neetha J. Standardizing glycemic management in high risk patients going for outpatient procedure. American College of Medical Quality Seminar, 2022. e-Pub 2022.
- Palma D, Thosani S. Quality improvement project on streamlining inpatient diabetes supplies for survival skill education and discharge planning, 2022. e-Pub 2022.
- Thosani S, Neetha Jawe MSN, CCRN. Optimizing standardized workflow for identification, monitoring and treatment of Patients with Type 1 diabetes or pumps undergoing outpatient procedures. Division of Internal Medicine research Retreat, 2022. e-Pub 2022.
- Taylor J, Felman B, Cain K, Iniesta M, Thosani SN, Earles T, Harris M, Raty S, Popovich S, Vu K, Best C, Schmeler K, Ramirez P, Meyer L. Surgical Universal euGlycemic Attainment during Recovery (SUGAR) Initiative: Sweet results through quality improvement. Annual Meeting on Womens Cancer, 2022. e-Pub 2022.
- Taylor J, MD, MPH, Raty S, MD, Lasala J, MD, Iniesta M, Cain K, PharmD, Horner A, MPAS, PA-C, Bruno M, Folloder J, MS, PA-C, Knippel S, APRN, Khanh V, MD, Popovich S, MD, Katz MH, MD, Best C, MD, Thosani S. Surgical Universal euGlycemic Attainment during Recovery (SUGAR Initiative): Sweet Results Through Standardization, Poster presentation, 2021. e-Pub 2021.
- Jeun R, Yedururi S, Lavis V, Best C, Varghese J, Glitza IC, Thosani S. Pancreatic volumes in immune checkpoint inhibitor-induced diabetes. American Society of Clinical oncology, 2021. e-Pub 2021.
- Varghese S, Dr Conor Best MD, Thosani, Sonali. Improving Hyperglycemia by Increasing the use of Basal Bolus Insulin Therapy. Division of Internal Medicine Research retreat, 2021.
- Jeun R, Thosani S. Causes of Diabetic Ketoacidosis among Adults Admitted to a Comprehensive Cancer Center, 2021. e-Pub 2021.
- Taylor J, Raty S, Khanh V, Popovich S, Best C, Kahn S, Thosani SN. Surgical euGlycemic Attainment during Recovery (SUGAR Initiative): Sweet Results Through Standardization, 2021. e-Pub 2021.
- Thosani S, Raty S, Gaeta S, Chen K, Taylor J, Thomas L, Weschler A, Horner A, Bowe C, Cavalier J, Benitez S, Gumban D, Folloder J, Drew T, Mart D, Shin D, Giang K, Monroe S, Koom-Dadzie K, Rajkot N, Richardson G, Tran J, Mathew J, Best C, Brady V, Lavis V, Wilson M, Levesque C, Ortiz M, Varghese J, Varghese S, Crowder V, John B, Ong J, Verallo C, Fajardo J, Ta-Ekasingh M, Parlikh M, Grami P, Kaur H, Estrella J, Bruno J, Horng M, Moser T, Walton N, Nugent A, Johnson C, Popat, U, Rizk M, Novicke B, DeCarlo R, Ali E, McCollough R, Warren M, Lopez K, Marts D, Goldschmidt P, Rice J, Zaghian M, Stone D, Kaufman L, Jawe N. Glycemic Action team (GlyCAT): reducing inpatient DKa in cancer patients. Institute of Healthcare Improvement Forum, 2021. e-Pub 2021.
- Jeun R, Best C, Iyer P, Lavis V, Varghese J, Glitza Oliva I, Dadu R, Thosani SN. “Immune Checkpoint Inhibitor Mediated Insulin Dependent Diabetes: Observations at a Cancer Center.”, 2021. e-Pub 2021.
- Jeun, Rebecca, Lavis V, Thosani ST. “DKA with Alpelesib”. Endocrine Society, 2021. e-Pub 2021.
- Mara Wilson MS, Zaghian M, Rice J, Warren ML, Joylynmae, Estrella, Parikh M, Stone D, Verallo C, Kaur H, Lopez K, Ong J, Ta-Ekasingh M, Fajardo J, Grami P, Susan Gaeta MD, Victor Lavis MD, Conor Best MD, Sonali Thosani MD. Improving Identification and Documentation of Patients utilizing insulin pumps at MD Anderson Cancer Center. Diabetes Therapeutics and Technology Meeting, 2020. e-Pub 2020.
- Thosani SN, Brady, Veronica. Prevalence of diabetes and hyperglycemia among cancer patients see in Emergency Department. Oncology emergency Medicine conference, 2020. e-Pub 2020.
- Thosani S, Best C, Lavis V, Habra M, Naifa Busaidy MD, Varghese J, Hu, Mimi, Maria Cabanillas MD, Ramona Dadu MD, Gagel R, Sherman S, Waguespack S, Steven Weitzman MD, Jimenez C, APRN CL, APRN MW, APRN MO, APRN SV, APRN VC, APRN JW, Feng C, Cue L, Cain K, Dang J, Simien RN, Velasquez RN, RN. Improving Documentation for Hypoglycemia Treatment in Hospitalized Patients at MD Anderson Cancer Center: 2012-2019, 2019.
- Taylor JS, Cain KC, Earles TR, Harris M, James D, Dottino J, Stewart K, McGrew L, Siebel C, Enbaya A, Donate M, Vacchani S, Lasala J, Thosani SN, Best C, Sahai S, Schlemer K, Ramirez P, Meyer L. Integration of a standardized Diabetic Management Protocol into an ERAS program, 2019. e-Pub 2019.
- Taylor JS, Cain KC, Earles TR, Harris M, James D, Dottino J, Stewart K, McGrew L, Siebel C, Enbaya A, Donate M, Vacchani S, Lasala J, Best C, Sahai S, Schlemer K, Ramirez P, Meyer L, Thosani SN. Sugar Universal euGlycemic Attainment during Recovery Initiative (SUGAR). Institute of Healthcare Improvement, 2018. e-Pub 2018.
- Iyer PI, Thosani SN. Euglycemic DKA as an initial presentation of Immunotherapy induced diabetes. American Diabetes Association, 2018. e-Pub 2018.
- Iyer P, Best C, Lavis V, Varghese J, Glitza I, Dadu R, Thosani SN. Immunotherapy induced insulin dependent diabetes: a cancer center experience. American Diabetes Association, 2018. e-Pub 2018.
- Mark C, Sonali T. External Radiation Therapy: A rare Cause of Thyroiditis. American Thyroid Association Meeting, 2017.
- Kariuki N, Thosani SN. Sclerosing mucoepidermoid carcinoma of the thyroid: A management predicament. Endocrine Society 2017, 2017. e-Pub 2017.
- Iyer P, Thosani SN. Immunotherapy induced Type 1 DM, 2016. e-Pub 2016.
- Thosani SN, Brady V, Cain K, Tran D, Cue L, Rollins J, Klimt B, Lavis V. Improving treatment of hypoglycemia inHospitalized cancer patients on insulin therapy through increased utilization of hypoglycemia Order set, 2015. e-Pub 2015.
- Thosani SN, Brady V. Safe and Effective Dosing of Basal-Bolus Insulin on patients, 2014. e-Pub 2014.
- Mulukutla, Surya, Thosani SN. "Hypoglycemia As the Initial Presentation of Gastrointestinal Stromal Tumor, 2014. e-Pub 2014.
- Dadu R, Devine C, Hernandez M, Busaidy N, Waguespack S, Ying A, Habra M, Thosani S, Hu M, Cabanillas M. Is Second-Line Targeted Therapy Beneficial in Patients (pts) with Differentiated Thyroid Cancer (DTC) After First-Line Sorafenib (SOR) Failure?. American Thyroid Association, 2013. e-Pub 2013.
- Dadu R, Thosani SN, Nalini R. The Hyperinsulinism Hyperammonemia Syndrome Complicated by Gestational Diabetes Mellitus, 2012. e-Pub 2012.
- Thosani SN, Busaidy N, Cabanillas M, Cote G, Grubbs E, Habra MA, Hu M, Perrier N, Ayala-Ramirez M, Rich T, Waguespack SG, Ying AK, Jimenez CJ. Characterization of Pheochromcoytomas in MEN 2 with RET codon 918 and 634 mutations, 2012. e-Pub 2012.
- Thosani SN, Waguespack SG, Lavis VA, Jimenez C. Interleukin-2 Therapy and the Extremes of Autoimmune Thyroid Disease, 2011. e-Pub 2011.
- Thosani SN, Edeiken-Monroe B, Jimenez C. Leukemic infiltration of the Thyroid Gland, 2011. e-Pub 2011.
Book Chapters
- Thosani S. Endocrine and Metabolic Complications of Cancer Therapy. In: MD Anderson Manual of Medical Oncology. 2. McGraw Hill, 2025.
- Hosein R, Bedrose S, Jeun R, Varghese JM, Thosani SN. “Endocrine and Metabolic Complications of Cancer Therapy”. In: The MD Anderson Manual of Medical Oncology. Fourth Edition. McGraw Hill, 2022.
- Sarimar A, Thosani SN. Thyroid Emergencies in Critically Ill Cancer Patients. In: Oncologic Critical Care. 1. Springer, 1200-1205, 2019.
- Thosani SN, Hu M, Ahn P, Lamont J. Thyroid and Parathyroid Cancers. In: Cancer Management: A Multidisciplinary Approach. 1. The Oncology Group, 1084, 2011.
- Milit P, Safia K, Michelle H, Sonya K, Sonali T. Hyperglycemic Emergencies in Critically Ill Cancer Patients. In: Oncologic Critical Care Textbook. Springer Hill.
- Chaudhri,Aysha, Thosani Sonali. Thyroid emergencies in Critically Ill Cancer Patients. In: Oncological Critical Care Textbook. Springer Hill.
Letters to the Editor
- Thosani N, Thosani SN, Singh H, Guha S. Reply to I.H. Sahin. Journal of Clinical Oncology, 2013.
Web Publications
- Thosani S, Alkon C. What to Do When It's Diabetes and Cancer; https://diatribe.org/diabetes-management/what-do-when-its-diabetes-and-cancer.
Patient Reviews
CV information above last modified January 14, 2026